Pulse Biosciences Inc (NASDAQ:PLSE) major shareholder Robert W. Duggan purchased 83,928 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The stock was bought at an average cost of $26.86 per share, with a total value of $2,254,306.08. Following the completion of the transaction, the insider now directly owns 3,054,244 shares in the company, valued at approximately $82,036,993.84. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Robert W. Duggan also recently made the following trade(s):
- On Monday, April 10th, Robert W. Duggan purchased 191,464 shares of Pulse Biosciences stock. The stock was bought at an average cost of $19.75 per share, with a total value of $3,781,414.00.
Pulse Biosciences Inc (NASDAQ:PLSE) traded up 3.51% during midday trading on Wednesday, reaching $29.23. The company had a trading volume of 198,213 shares. The stock’s market capitalization is $414.34 million. The company has a 50-day moving average of $24.33 and a 200-day moving average of $14.28. Pulse Biosciences Inc has a 12-month low of $4.03 and a 12-month high of $35.93.
Pulse Biosciences (NASDAQ:PLSE) last announced its quarterly earnings data on Thursday, May 4th. The company reported ($0.23) earnings per share (EPS) for the quarter.
COPYRIGHT VIOLATION WARNING: This piece was published by sleekmoney and is owned by of sleekmoney. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://sleekmoney.com/pulse-biosciences-inc-plse-major-shareholder-acquires-2254306-08-in-stock/1850951.html.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/pulse-biosciences-inc-plse-major-shareholder-acquires-2254306-08-in-stock/1850951.html
Receive News & Ratings for Pulse Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.